Correlation Between Celularity and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Celularity and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celularity and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celularity and EFFECTOR Therapeutics, you can compare the effects of market volatilities on Celularity and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celularity with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celularity and EFFECTOR Therapeutics.
Diversification Opportunities for Celularity and EFFECTOR Therapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Celularity and EFFECTOR is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Celularity and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and Celularity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celularity are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of Celularity i.e., Celularity and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between Celularity and EFFECTOR Therapeutics
Given the investment horizon of 90 days Celularity is expected to generate 3.02 times less return on investment than EFFECTOR Therapeutics. But when comparing it to its historical volatility, Celularity is 3.09 times less risky than EFFECTOR Therapeutics. It trades about 0.01 of its potential returns per unit of risk. EFFECTOR Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 18.00 in EFFECTOR Therapeutics on September 1, 2024 and sell it today you would lose (17.90) from holding EFFECTOR Therapeutics or give up 99.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 38.3% |
| Values | Daily Returns |
Celularity vs. EFFECTOR Therapeutics
Performance |
| Timeline |
| Celularity |
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Celularity and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Celularity and EFFECTOR Therapeutics
The main advantage of trading using opposite Celularity and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celularity position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.| Celularity vs. Immix Biopharma | Celularity vs. ZyVersa Therapeutics | Celularity vs. Hepion Pharmaceuticals | Celularity vs. Cns Pharmaceuticals |
| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |